With our Aescuvest-Blog around the topic of crowdfunding we would like to keep you always up to date. Articles, current news and expert knowledge from the world of health, finance and on various developments in the healthcare sector, from crowdfunding to IPOs.
Where Equity Crowdfunding Fits Into An Investment Portfolio
Venture capital is no longer the exclusive preserve of the wealthy, says bestselling author Nathan Rose. Startups are building the economy of the future. They are disrupting old markets and finding new ways to solve problems. Wealthy investors have always been able to invest in these types of exciting opportunities and enjoy the potential for outsized returns in the event the companies achieve their ambitions.
In its early days, the self-driving technology firm Cruise Automation went the crowdfunding route, raising a mere $200,000. In 2016, just two years after that first crowdfunding push, Cruise Automation was acquired by General Motors for a mind-blowing $1 billion in cash and stock, making the company the first billion-dollar exit for equity-based crowdfunding, a unicorn you can ride.
European Health Catapult Open for New Applications
Start-ups, watch out: doors have been opened to enter the European Health Catapult Competition Vintage 2020. Catapult is EIT Health’s individualized training program and competition that aims to boost the development and visibility of high-potential European health start-ups.
What Does “Prospectus-approved” Mean for an Investor?
On aescuvest.eu, investors become participants in the business chances of a start-up based on security investments. In order to issue and distribute shares Europe-wide, the start-up has to prepare a comprehensive offering document: the so-called prospectus has to be approved by a European financial authority before publishing, in this case by BaFin, Germany’s Federal Financial Supervisory Authority. What does this mean for the investors?
Health investors and entrepreneurs alike have a common place to travel to each January: California. And this is not due to the lack of sunshine that we usually experience in many regions of the northern hemisphere at this time of the year.
The Three Pillars of Surge-on Medical’s Business Model
Just in case you are wondering how Surge-on Medical makes money, look no further. We do not solely rely on the unique surgical instruments we are developing. In fact, our patented platform technology enables us to have multiple revenue streams we would like to share with you.
So, let’s take a look at Surge-on Medical’s business model that is built on three pillars, namely product sales, IP licenses and contract research.
With the regulatory recommendations to switch to cleanable and reusable surgical instruments, several medical companies find themselves struggling to adapt. Most of the already established medical companies supply robust and stiff instruments, while others offer a few complex steering systems that must be discarded after being used a couple of times.
In Germany Digital Health Acts on Official Mission
On November 7, 2019, the Bundestag, Germany’s federal parliament, passed a bill that ushers in a new digital age. The new law – in short form called ‘Digital Care Act’ – will come into effect in early 2020. It will allow physicians to prescribe digital health applications that support or monitor patients; and its official mission is described in the long form of the name: “to enhance medical care through digitization and innovation”.
The Added Value of Steerable Instruments in Orthopaedic Surgery
The Operating Room’s Perspective, Part 1:
As Surge-on Medical’s main goal is to empower surgeons, we took on the task of interviewing surgeons and medical practitioners in the orthopaedic area to better understand their perspective on their struggles and their opinion on the Steerable Punch.